Swiss-based MedTech Startup EBAMed Appoints Marina Izzo as CEO

GENEVA–(BUSINESS WIRE)–EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead the effort for the next financing round, planned for 2022. Former CEO and co-founder, […]

EBAMed is Awarded EUR 2.4 Million by the European Union to Develop Its Cardiac Motion Management Product for the Non-invasive Treatment of Heart Arrhythmias

GENEVA–(BUSINESS WIRE)–EBAMed SA, a medical technology company based in Geneva, Switzerland, has been awarded EUR 2.4 million in a non-dilutive grant (agreement No. 954783) by the Enhanced European Innovation Council (EIC) to develop its cardiac motion management product for the non-invasive treatment of heart arrhythmias. The grant enables EBAMed to […]